Your browser doesn't support javascript.
loading
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.
van Amerongen, Rosa A; Tuit, Sander; Wouters, Anne K; van de Meent, Marian; Siekman, Sterre L; Meeuwsen, Miranda H; Wachsmann, Tassilo L A; Remst, Dennis F G; Hagedoorn, Renate S; van der Steen, Dirk M; de Ru, Arnoud H; Verdegaal, Els M E; van Veelen, Peter A; Falkenburg, J H Frederik; Heemskerk, Mirjam H M.
Afiliação
  • van Amerongen RA; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • Tuit S; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • Wouters AK; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • van de Meent M; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • Siekman SL; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • Meeuwsen MH; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • Wachsmann TLA; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • Remst DFG; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • Hagedoorn RS; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • van der Steen DM; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • de Ru AH; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
  • Verdegaal EME; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands.
  • van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
  • Falkenburg JHF; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
  • Heemskerk MHM; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
Front Immunol ; 14: 1121973, 2023.
Article em En | MEDLINE | ID: mdl-37026005

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Receptores de Antígenos de Linfócitos T Limite: Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Receptores de Antígenos de Linfócitos T Limite: Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda